About: covid:PMC7194685

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7194685 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Bishop, Michael Dholaria, Bhagirathbhai Maziarz, Richard Bachanova, Veronika Dahi, Parastoo Grupp, Stephan Hayes-Lattin, Brandon Janakiram, Murali McGuirk, Joseph Nastoupil, Loretta Oluwole, Olalekan Perales, Miguel-Angel Porter, David Riedell, Peter
is schema:about of	named entity 'Therapy' named entity 'Chimeric Antigen Receptor T Cell' named entity 'immunocompromised' named entity 'respiratory symptoms' named entity 'antiviral' named entity 'disease burden' named entity 'CAR T cell' named entity 'Novartis' named entity 'multidisciplinary team' named entity 'CDC' named entity 'CAR T cell' named entity 'CAR T cell' named entity 'Genentech' named entity 'Novartis' named entity 'CAR T cell' named entity 'National Marrow Donor Program' named entity 'clinical trials' named entity 'ECOG' named entity 'cellular therapy' named entity 'viral transmission' named entity 'COVID-19' named entity 'neutropenia' named entity 'phase II studies' named entity 'parenteral' named entity 'Novartis' named entity 'COVID-19 pandemic' named entity 'acute toxicity' named entity 'CRS' named entity 'outpatient clinics' named entity 'Celgene' named entity 'virtual team' named entity 'infection' named entity 'personal protective equipment' named entity 'ICU' named entity 'performance status' named entity 'antimicrobial prophylaxis' named entity 'neurotoxicity' named entity 'CAR T cell' named entity 'neutropenia' named entity 'neurotoxicity' named entity 'neurotoxicity' named entity 'research funding' named entity 'functional status' named entity 'Genentech' named entity 'Kite Pharma' named entity 'tocilizumab' named entity 'telemedicine' named entity 'CAR T cell' named entity 'performance status' named entity 'CRS' named entity 'CAR T cell' named entity 'cellular therapy' named entity 'organ' named entity 'Servier' named entity 'COVID-19 pandemic' named entity 'decision making' named entity 'tocilizumab' named entity 'performance status' named entity 'COVID-19' named entity 'disease burden' named entity 'COVID-19 pandemic' named entity 'lactate dehydrogenase' named entity 'Kite Pharma' named entity 'COVID-19 pandemic' named entity 'CAR T cell' named entity 'Celgene' named entity 'autologous stem cell transplantation' named entity 'cellular therapy' named entity 'recombinant monoclonal antibody' named entity 'pharmacokinetic' named entity 'NHL' named entity 'research funding' named entity 'hepatic' named entity 'tumor' named entity 'Risk Evaluation and Mitigation Strategies' named entity 'COVID-19 pandemic' named entity 'Incyte' named entity 'CAR T cell' named entity 'Jazz Pharmaceuticals' named entity 'Kite Pharma' named entity 'first-line' named entity 'clinical trials' named entity 'COVID-19' named entity 'performance status' named entity 'intensive care' named entity 'study endpoint'

Attributes

Values

Creator

Bishop, Michael
Dholaria, Bhagirathbhai
Maziarz, Richard
Bachanova, Veronika
Dahi, Parastoo
Grupp, Stephan
Hayes-Lattin, Brandon
Janakiram, Murali
McGuirk, Joseph
Nastoupil, Loretta
Oluwole, Olalekan
Perales, Miguel-Angel
Porter, David
Riedell, Peter

is schema:about of

named entity 'Therapy'
named entity 'Chimeric Antigen Receptor T Cell'
named entity 'immunocompromised'
named entity 'respiratory symptoms'
named entity 'antiviral'
named entity 'disease burden'
named entity 'CAR T cell'
named entity 'Novartis'
named entity 'multidisciplinary team'
named entity 'CDC'
named entity 'CAR T cell'
named entity 'CAR T cell'
named entity 'Genentech'
named entity 'Novartis'
named entity 'CAR T cell'
named entity 'National Marrow Donor Program'
named entity 'clinical trials'
named entity 'ECOG'
named entity 'cellular therapy'
named entity 'viral transmission'
named entity 'COVID-19'
named entity 'neutropenia'
named entity 'phase II studies'
named entity 'parenteral'
named entity 'Novartis'
named entity 'COVID-19 pandemic'
named entity 'acute toxicity'
named entity 'CRS'
named entity 'outpatient clinics'
named entity 'Celgene'
named entity 'virtual team'
named entity 'infection'
named entity 'personal protective equipment'
named entity 'ICU'
named entity 'performance status'
named entity 'antimicrobial prophylaxis'
named entity 'neurotoxicity'
named entity 'CAR T cell'
named entity 'neutropenia'
named entity 'neurotoxicity'
named entity 'neurotoxicity'
named entity 'research funding'
named entity 'functional status'
named entity 'Genentech'
named entity 'Kite Pharma'
named entity 'tocilizumab'
named entity 'telemedicine'
named entity 'CAR T cell'
named entity 'performance status'
named entity 'CRS'
named entity 'CAR T cell'
named entity 'cellular therapy'
named entity 'organ'
named entity 'Servier'
named entity 'COVID-19 pandemic'
named entity 'decision making'
named entity 'tocilizumab'
named entity 'performance status'
named entity 'COVID-19'
named entity 'disease burden'
named entity 'COVID-19 pandemic'
named entity 'lactate dehydrogenase'
named entity 'Kite Pharma'
named entity 'COVID-19 pandemic'
named entity 'CAR T cell'
named entity 'Celgene'
named entity 'autologous stem cell transplantation'
named entity 'cellular therapy'
named entity 'recombinant monoclonal antibody'
named entity 'pharmacokinetic'
named entity 'NHL'
named entity 'research funding'
named entity 'hepatic'
named entity 'tumor'
named entity 'Risk Evaluation and Mitigation Strategies'
named entity 'COVID-19 pandemic'
named entity 'Incyte'
named entity 'CAR T cell'
named entity 'Jazz Pharmaceuticals'
named entity 'Kite Pharma'
named entity 'first-line'
named entity 'clinical trials'
named entity 'COVID-19'
named entity 'performance status'
named entity 'intensive care'
named entity 'study endpoint'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software